Structure

Physi-Chem Properties

Molecular Weight:  544.12
Volume:  509.298
LogP:  2.334
LogD:  1.189
LogS:  -3.362
# Rotatable Bonds:  9
TPSA:  212.67
# H-Bond Aceptor:  13
# H-Bond Donor:  7
# Rings:  4
# Heavy Atoms:  13

MedChem Properties

QED Drug-Likeness Score:  0.164
Synthetic Accessibility Score:  3.887
Fsp3:  0.231
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Rejected
Chelating Alert:  1
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.569
MDCK Permeability:  1.6879284885362722e-05
Pgp-inhibitor:  0.016
Pgp-substrate:  0.001
Human Intestinal Absorption (HIA):  0.682
20% Bioavailability (F20%):  0.53
30% Bioavailability (F30%):  1.0

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.07
Plasma Protein Binding (PPB):  98.73210906982422%
Volume Distribution (VD):  0.508
Pgp-substrate:  3.631533622741699%

ADMET: Metabolism

CYP1A2-inhibitor:  0.515
CYP1A2-substrate:  0.02
CYP2C19-inhibitor:  0.187
CYP2C19-substrate:  0.041
CYP2C9-inhibitor:  0.539
CYP2C9-substrate:  0.427
CYP2D6-inhibitor:  0.708
CYP2D6-substrate:  0.176
CYP3A4-inhibitor:  0.391
CYP3A4-substrate:  0.052

ADMET: Excretion

Clearance (CL):  12.461
Half-life (T1/2):  0.952

ADMET: Toxicity

hERG Blockers:  0.167
Human Hepatotoxicity (H-HT):  0.032
Drug-inuced Liver Injury (DILI):  0.915
AMES Toxicity:  0.128
Rat Oral Acute Toxicity:  0.019
Maximum Recommended Daily Dose:  0.002
Skin Sensitization:  0.946
Carcinogencity:  0.256
Eye Corrosion:  0.003
Eye Irritation:  0.916
Respiratory Toxicity:  0.008

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC90905

Natural Product ID:  NPC90905
Common Name*:   Hyemaloside B
IUPAC Name:   [(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-[(4-hydroxybenzoyl)oxymethyl]-2-(4-hydroxyphenoxy)oxan-3-yl] 3,4,5-trihydroxybenzoate
Synonyms:  
Standard InCHIKey:  LIANLIDDEFJTSX-XZWSAFPPSA-N
Standard InCHI:  InChI=1S/C26H24O13/c27-14-3-1-12(2-4-14)24(34)36-11-19-21(32)22(33)23(26(38-19)37-16-7-5-15(28)6-8-16)39-25(35)13-9-17(29)20(31)18(30)10-13/h1-10,19,21-23,26-33H,11H2/t19-,21-,22+,23-,26-/m1/s1
SMILES:  Oc1ccc(cc1)O[C@@H]1O[C@H](COC(=O)c2ccc(cc2)O)[C@H]([C@@H]([C@H]1OC(=O)c1cc(O)c(c(c1)O)O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL498793
PubChem CID:   25110931
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0004603] Organic oxygen compounds
      • [CHEMONTID:0000323] Organooxygen compounds
        • [CHEMONTID:0000011] Carbohydrates and carbohydrate conjugates
          • [CHEMONTID:0002105] Glycosyl compounds
            • [CHEMONTID:0004165] Phenolic glycosides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO27524 Eugenia hyemalis Species Myrtaceae Eukaryota n.a. n.a. n.a. PMID[18763827]
NPO27524 Eugenia hyemalis Species Myrtaceae Eukaryota n.a. whole plant n.a. PMID[18763827]
NPO27524 Eugenia hyemalis Species Myrtaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT2 Others Unspecified IC50 > 18300.0 nM PMID[449594]
NPT2 Others Unspecified IC50 = 3320.0 nM PMID[449594]
NPT2 Others Unspecified IC50 = 2440.0 nM PMID[449594]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC90905 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC4013
0.9869 High Similarity NPC289346
0.9804 High Similarity NPC74319
0.9804 High Similarity NPC287872
0.9742 High Similarity NPC33298
0.9742 High Similarity NPC285108
0.9684 High Similarity NPC95421
0.9684 High Similarity NPC198125
0.9677 High Similarity NPC311803
0.9677 High Similarity NPC472859
0.9677 High Similarity NPC25389
0.9613 High Similarity NPC166277
0.9613 High Similarity NPC119125
0.9563 High Similarity NPC5786
0.9563 High Similarity NPC102851
0.9548 High Similarity NPC289811
0.9548 High Similarity NPC160780
0.9487 High Similarity NPC239966
0.9487 High Similarity NPC203020
0.9484 High Similarity NPC1913
0.9484 High Similarity NPC133984
0.9437 High Similarity NPC658
0.9437 High Similarity NPC197708
0.9387 High Similarity NPC472992
0.9387 High Similarity NPC472991
0.9379 High Similarity NPC149011
0.9379 High Similarity NPC204937
0.9359 High Similarity NPC472860
0.9351 High Similarity NPC3746
0.9351 High Similarity NPC205037
0.9351 High Similarity NPC44260
0.9351 High Similarity NPC16024
0.9351 High Similarity NPC61152
0.9329 High Similarity NPC476622
0.9329 High Similarity NPC476618
0.9329 High Similarity NPC476620
0.9329 High Similarity NPC476623
0.9329 High Similarity NPC476619
0.9329 High Similarity NPC476621
0.9308 High Similarity NPC121290
0.929 High Similarity NPC327032
0.929 High Similarity NPC191046
0.929 High Similarity NPC194095
0.9264 High Similarity NPC175230
0.9264 High Similarity NPC163165
0.9264 High Similarity NPC172033
0.9264 High Similarity NPC88560
0.9241 High Similarity NPC24164
0.9236 High Similarity NPC156818
0.9236 High Similarity NPC68324
0.9236 High Similarity NPC289322
0.9236 High Similarity NPC38779
0.9236 High Similarity NPC160512
0.9236 High Similarity NPC114179
0.9226 High Similarity NPC310661
0.9226 High Similarity NPC105827
0.9221 High Similarity NPC140151
0.9216 High Similarity NPC92117
0.9212 High Similarity NPC472387
0.9207 High Similarity NPC84482
0.9207 High Similarity NPC169645
0.9202 High Similarity NPC47140
0.9202 High Similarity NPC254540
0.9202 High Similarity NPC172807
0.9202 High Similarity NPC211594
0.9202 High Similarity NPC67134
0.9198 High Similarity NPC149300
0.9172 High Similarity NPC471405
0.9172 High Similarity NPC250436
0.9172 High Similarity NPC300845
0.9172 High Similarity NPC88803
0.9172 High Similarity NPC104983
0.9172 High Similarity NPC291948
0.9162 High Similarity NPC36138
0.9161 High Similarity NPC134905
0.9161 High Similarity NPC36130
0.9152 High Similarity NPC67629
0.9152 High Similarity NPC79736
0.9152 High Similarity NPC61904
0.9152 High Similarity NPC144097
0.915 High Similarity NPC120621
0.915 High Similarity NPC248257
0.9146 High Similarity NPC472993
0.9141 High Similarity NPC34287
0.9141 High Similarity NPC471416
0.9136 High Similarity NPC473818
0.9136 High Similarity NPC45618
0.9136 High Similarity NPC116745
0.9136 High Similarity NPC58716
0.9136 High Similarity NPC146792
0.913 High Similarity NPC142614
0.9125 High Similarity NPC148273
0.9119 High Similarity NPC53889
0.9114 High Similarity NPC238419
0.9114 High Similarity NPC172419
0.9108 High Similarity NPC10205
0.9107 High Similarity NPC470416
0.9103 High Similarity NPC157898
0.9102 High Similarity NPC8940
0.9097 High Similarity NPC93619
0.9096 High Similarity NPC113836
0.9096 High Similarity NPC37668
0.9096 High Similarity NPC253521
0.9096 High Similarity NPC267549
0.9096 High Similarity NPC35167
0.9091 High Similarity NPC135277
0.9091 High Similarity NPC34267
0.9091 High Similarity NPC49344
0.9091 High Similarity NPC210094
0.9091 High Similarity NPC101191
0.9091 High Similarity NPC477848
0.9091 High Similarity NPC43211
0.9091 High Similarity NPC237435
0.9091 High Similarity NPC223426
0.9091 High Similarity NPC81042
0.9091 High Similarity NPC214621
0.9091 High Similarity NPC115760
0.9085 High Similarity NPC307518
0.9085 High Similarity NPC48773
0.9085 High Similarity NPC205076
0.9085 High Similarity NPC472386
0.908 High Similarity NPC201292
0.908 High Similarity NPC226294
0.908 High Similarity NPC186807
0.908 High Similarity NPC170675
0.908 High Similarity NPC112755
0.908 High Similarity NPC93337
0.908 High Similarity NPC471457
0.908 High Similarity NPC45638
0.908 High Similarity NPC105025
0.908 High Similarity NPC58053
0.908 High Similarity NPC475942
0.908 High Similarity NPC469931
0.9068 High Similarity NPC88043
0.9068 High Similarity NPC168822
0.9062 High Similarity NPC217950
0.9057 High Similarity NPC87317
0.9051 High Similarity NPC318432
0.9051 High Similarity NPC247629
0.9051 High Similarity NPC239019
0.9038 High Similarity NPC75695
0.9036 High Similarity NPC268533
0.9036 High Similarity NPC211532
0.9036 High Similarity NPC297574
0.9036 High Similarity NPC472385
0.9036 High Similarity NPC198324
0.9036 High Similarity NPC154741
0.9036 High Similarity NPC233994
0.9036 High Similarity NPC296018
0.9026 High Similarity NPC142528
0.9024 High Similarity NPC183357
0.9024 High Similarity NPC155763
0.9024 High Similarity NPC245014
0.9024 High Similarity NPC20505
0.9024 High Similarity NPC235260
0.9024 High Similarity NPC44558
0.9024 High Similarity NPC21190
0.9024 High Similarity NPC474434
0.9024 High Similarity NPC84265
0.9024 High Similarity NPC22195
0.9024 High Similarity NPC282987
0.9024 High Similarity NPC224462
0.9024 High Similarity NPC105511
0.9018 High Similarity NPC45400
0.9012 High Similarity NPC165720
0.9006 High Similarity NPC77660
0.9006 High Similarity NPC189142
0.9006 High Similarity NPC41009
0.9 High Similarity NPC476373
0.8988 High Similarity NPC53680
0.8988 High Similarity NPC208797
0.8987 High Similarity NPC145425
0.8982 High Similarity NPC476773
0.8982 High Similarity NPC217520
0.8982 High Similarity NPC139571
0.8982 High Similarity NPC196127
0.8982 High Similarity NPC293626
0.8982 High Similarity NPC217387
0.8982 High Similarity NPC258044
0.8982 High Similarity NPC267680
0.8981 High Similarity NPC474656
0.8981 High Similarity NPC137813
0.8976 High Similarity NPC264735
0.897 High Similarity NPC289396
0.897 High Similarity NPC3583
0.897 High Similarity NPC190003
0.897 High Similarity NPC212038
0.897 High Similarity NPC81332
0.897 High Similarity NPC301683
0.897 High Similarity NPC117260
0.897 High Similarity NPC271848
0.897 High Similarity NPC175107
0.897 High Similarity NPC476405
0.897 High Similarity NPC262580
0.897 High Similarity NPC259152
0.8968 High Similarity NPC111785
0.8963 High Similarity NPC95855
0.8963 High Similarity NPC229687
0.8963 High Similarity NPC138927
0.8963 High Similarity NPC472383

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC90905 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9172 High Similarity NPD4868 Clinical (unspecified phase)
0.9091 High Similarity NPD4338 Clinical (unspecified phase)
0.8788 High Similarity NPD3818 Discontinued
0.8735 High Similarity NPD7054 Approved
0.8683 High Similarity NPD7074 Phase 3
0.8683 High Similarity NPD7472 Approved
0.8642 High Similarity NPD4381 Clinical (unspecified phase)
0.8631 High Similarity NPD6797 Phase 2
0.8631 High Similarity NPD7993 Clinical (unspecified phase)
0.8608 High Similarity NPD1653 Approved
0.858 High Similarity NPD7251 Discontinued
0.8512 High Similarity NPD5844 Phase 1
0.8443 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.8443 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.8443 Intermediate Similarity NPD6166 Phase 2
0.8421 Intermediate Similarity NPD7808 Phase 3
0.8363 Intermediate Similarity NPD7685 Pre-registration
0.8344 Intermediate Similarity NPD6190 Approved
0.8344 Intermediate Similarity NPD2801 Approved
0.8313 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.8282 Intermediate Similarity NPD1934 Approved
0.8232 Intermediate Similarity NPD1465 Phase 2
0.8232 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.8182 Intermediate Similarity NPD5402 Approved
0.815 Intermediate Similarity NPD6559 Discontinued
0.8129 Intermediate Similarity NPD7228 Approved
0.8117 Intermediate Similarity NPD230 Phase 1
0.8089 Intermediate Similarity NPD7266 Discontinued
0.8081 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.8072 Intermediate Similarity NPD3817 Phase 2
0.8049 Intermediate Similarity NPD4380 Phase 2
0.8047 Intermediate Similarity NPD7199 Phase 2
0.8036 Intermediate Similarity NPD6234 Discontinued
0.8024 Intermediate Similarity NPD3882 Suspended
0.8012 Intermediate Similarity NPD1511 Approved
0.8012 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7976 Intermediate Similarity NPD7075 Discontinued
0.7966 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7952 Intermediate Similarity NPD37 Approved
0.7944 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7917 Intermediate Similarity NPD4967 Phase 2
0.7917 Intermediate Similarity NPD4966 Approved
0.7917 Intermediate Similarity NPD4965 Approved
0.7914 Intermediate Similarity NPD1512 Approved
0.7895 Intermediate Similarity NPD6232 Discontinued
0.7892 Intermediate Similarity NPD7411 Suspended
0.7882 Intermediate Similarity NPD5494 Approved
0.7853 Intermediate Similarity NPD8312 Approved
0.7853 Intermediate Similarity NPD8313 Approved
0.7849 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7833 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7826 Intermediate Similarity NPD4628 Phase 3
0.7816 Intermediate Similarity NPD3751 Discontinued
0.7798 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7798 Intermediate Similarity NPD8455 Phase 2
0.7759 Intermediate Similarity NPD7473 Discontinued
0.7758 Intermediate Similarity NPD5403 Approved
0.7738 Intermediate Similarity NPD6801 Discontinued
0.7707 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7707 Intermediate Similarity NPD1613 Approved
0.7702 Intermediate Similarity NPD1549 Phase 2
0.7692 Intermediate Similarity NPD7819 Suspended
0.7688 Intermediate Similarity NPD3787 Discontinued
0.7683 Intermediate Similarity NPD6799 Approved
0.7647 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.764 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.764 Intermediate Similarity NPD7240 Approved
0.764 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7636 Intermediate Similarity NPD5401 Approved
0.7607 Intermediate Similarity NPD3750 Approved
0.76 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7558 Intermediate Similarity NPD3749 Approved
0.7546 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7532 Intermediate Similarity NPD6233 Phase 2
0.753 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.753 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7529 Intermediate Similarity NPD6959 Discontinued
0.7526 Intermediate Similarity NPD7783 Phase 2
0.7526 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7526 Intermediate Similarity NPD7435 Discontinued
0.7516 Intermediate Similarity NPD3027 Phase 3
0.7516 Intermediate Similarity NPD9269 Phase 2
0.7513 Intermediate Similarity NPD8151 Discontinued
0.75 Intermediate Similarity NPD7768 Phase 2
0.7469 Intermediate Similarity NPD1551 Phase 2
0.7468 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.746 Intermediate Similarity NPD6780 Approved
0.746 Intermediate Similarity NPD6779 Approved
0.746 Intermediate Similarity NPD6782 Approved
0.746 Intermediate Similarity NPD6777 Approved
0.746 Intermediate Similarity NPD6776 Approved
0.746 Intermediate Similarity NPD6781 Approved
0.746 Intermediate Similarity NPD6778 Approved
0.7452 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7442 Intermediate Similarity NPD5353 Approved
0.7438 Intermediate Similarity NPD1933 Approved
0.7425 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7412 Intermediate Similarity NPD6599 Discontinued
0.7407 Intermediate Similarity NPD1510 Phase 2
0.7394 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7389 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7389 Intermediate Similarity NPD9494 Approved
0.7362 Intermediate Similarity NPD2935 Discontinued
0.7362 Intermediate Similarity NPD2796 Approved
0.7353 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7344 Intermediate Similarity NPD7680 Approved
0.7329 Intermediate Similarity NPD447 Suspended
0.7316 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7306 Intermediate Similarity NPD7871 Phase 2
0.7306 Intermediate Similarity NPD7870 Phase 2
0.7301 Intermediate Similarity NPD3748 Approved
0.7296 Intermediate Similarity NPD7874 Approved
0.7296 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7282 Intermediate Similarity NPD7585 Approved
0.7273 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7267 Intermediate Similarity NPD943 Approved
0.7255 Intermediate Similarity NPD9268 Approved
0.7254 Intermediate Similarity NPD7696 Phase 3
0.7254 Intermediate Similarity NPD7698 Approved
0.7254 Intermediate Similarity NPD7697 Approved
0.7253 Intermediate Similarity NPD7039 Approved
0.7253 Intermediate Similarity NPD7038 Approved
0.7251 Intermediate Similarity NPD7458 Discontinued
0.7247 Intermediate Similarity NPD5242 Approved
0.7231 Intermediate Similarity NPD7583 Approved
0.7226 Intermediate Similarity NPD1091 Approved
0.7202 Intermediate Similarity NPD6823 Phase 2
0.7196 Intermediate Similarity NPD6535 Approved
0.7196 Intermediate Similarity NPD6534 Approved
0.7194 Intermediate Similarity NPD7701 Phase 2
0.7168 Intermediate Similarity NPD6385 Approved
0.7168 Intermediate Similarity NPD6386 Approved
0.716 Intermediate Similarity NPD1240 Approved
0.7151 Intermediate Similarity NPD8434 Phase 2
0.7151 Intermediate Similarity NPD3926 Phase 2
0.7143 Intermediate Similarity NPD7584 Approved
0.7143 Intermediate Similarity NPD3764 Approved
0.7143 Intermediate Similarity NPD6798 Discontinued
0.7135 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.7135 Intermediate Similarity NPD1247 Approved
0.7135 Intermediate Similarity NPD8127 Discontinued
0.7134 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7125 Intermediate Similarity NPD4908 Phase 1
0.712 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.712 Intermediate Similarity NPD7549 Discontinued
0.7119 Intermediate Similarity NPD919 Approved
0.7118 Intermediate Similarity NPD2532 Approved
0.7118 Intermediate Similarity NPD2533 Approved
0.7118 Intermediate Similarity NPD2534 Approved
0.7085 Intermediate Similarity NPD7801 Approved
0.7083 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7083 Intermediate Similarity NPD7700 Phase 2
0.7083 Intermediate Similarity NPD7699 Phase 2
0.7078 Intermediate Similarity NPD9545 Approved
0.7076 Intermediate Similarity NPD6273 Approved
0.7073 Intermediate Similarity NPD1607 Approved
0.7062 Intermediate Similarity NPD6971 Discontinued
0.7059 Intermediate Similarity NPD8150 Discontinued
0.7052 Intermediate Similarity NPD3226 Approved
0.7044 Intermediate Similarity NPD1203 Approved
0.7037 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.703 Intermediate Similarity NPD7097 Phase 1
0.7024 Intermediate Similarity NPD1652 Phase 2
0.7024 Intermediate Similarity NPD6674 Discontinued
0.7024 Intermediate Similarity NPD8155 Clinical (unspecified phase)
0.7011 Intermediate Similarity NPD5953 Discontinued
0.7 Intermediate Similarity NPD7440 Discontinued
0.7 Intermediate Similarity NPD7229 Phase 3
0.6981 Remote Similarity NPD3225 Approved
0.6971 Remote Similarity NPD7615 Clinical (unspecified phase)
0.6963 Remote Similarity NPD6213 Phase 3
0.6963 Remote Similarity NPD6214 Clinical (unspecified phase)
0.6963 Remote Similarity NPD6212 Phase 3
0.6962 Remote Similarity NPD1608 Approved
0.6962 Remote Similarity NPD1481 Phase 2
0.6954 Remote Similarity NPD8320 Phase 1
0.6954 Remote Similarity NPD3455 Phase 2
0.6954 Remote Similarity NPD8319 Approved
0.6936 Remote Similarity NPD920 Approved
0.6919 Remote Similarity NPD642 Clinical (unspecified phase)
0.6914 Remote Similarity NPD6832 Phase 2
0.6909 Remote Similarity NPD5124 Phase 1
0.6909 Remote Similarity NPD1899 Clinical (unspecified phase)
0.6909 Remote Similarity NPD5123 Clinical (unspecified phase)
0.6902 Remote Similarity NPD7286 Phase 2
0.6899 Remote Similarity NPD1535 Discovery
0.6886 Remote Similarity NPD651 Clinical (unspecified phase)
0.6886 Remote Similarity NPD7033 Discontinued
0.6882 Remote Similarity NPD8166 Discontinued
0.686 Remote Similarity NPD4357 Discontinued
0.6854 Remote Similarity NPD4288 Approved
0.6852 Remote Similarity NPD2861 Phase 2
0.6845 Remote Similarity NPD6099 Approved
0.6845 Remote Similarity NPD6100 Approved
0.6837 Remote Similarity NPD7501 Clinical (unspecified phase)
0.6836 Remote Similarity NPD6844 Discontinued
0.6829 Remote Similarity NPD2313 Discontinued
0.6807 Remote Similarity NPD6355 Discontinued
0.6805 Remote Similarity NPD2346 Discontinued
0.6802 Remote Similarity NPD643 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data